Loading

Sessions

  • by Paul Armentano, NORML Deputy Director November 5, 2018

    Texas Republican and ardent marijuana prohibitionist Pete Sessions trails by four points in his re-election bid, according to polling data released yesterday. According to the survey results, Sessions is behind Democratic challenger Colin Allred by a margin of 46 percent to 42 percent in the race for Texas’ 32nd Congressional District.

    As a member of Congress, Sessions has been one of the nation’s most vocal and powerful forces against our efforts to enact sensible marijuana policy reforms. Speaking publicly on the issue earlier this year, Sessions opined: “Marijuana is an addictive product, and the merchants of addiction make it that way. They make it to where our people, our young people, become addicted to marijuana and keep going.”

    As I wrote last month in my ‘Marijuana and the midterms” op-ed in The Hill, “Pete Sessions has used his position as Chairman of the House Rules Committee to block House floor members from voting on over three-dozen marijuana-related amendments during his leadership tenure.” His actions have almost single-handedly killed a number of popular, bipartisan-led reforms — such as facilitating medical cannabis access to military veterans and amending federal banking laws so that licensed marijuana businesses are treated like other legal industries.

    Representative Sessions received an ‘F’ grade in NORML’s latest Congressional Scorecard. By contrast, his Democratic challenger received a B+ grade as a result of his stated support for cannabis decriminalization and medical marijuana access.

    Texas’ 32nd Congressional District represents the city of Garland and the northeastern section of Dallas.

  • by Erik Altieri, NORML Executive Director June 27, 2018

    Representative Jared Polis, who was endorsed by NORML PAC, scored a resounding victory in Colorado’s Democratic primary for governor.

    The results from the Democratic gubernatorial primary are not just a victory for Jared Polis and supporters of sensible marijuana policy, they are a victory for anyone who believes that our prohibition on marijuana is a failure and that states should be free to set their own policies when it comes to cannabis, free from federal incursion. Jared Polis has been the preeminent champion for ending our nation’s failed federal prohibition on marijuana while in Congress and an unrelenting force in standing up for Colorado’s legalization and medical marijuana laws. Just as he has always stood and fought by our side against federal prohibition, we will continue to fight for Jared Polis until he takes his rightful place in the governor’s mansion.

    Upon receiving our endorsement, Polis stated, “I’ve been proud to lead the fight for cannabis reform in Congress, and NORML has been an incredibly valuable partner in that effort, Here in Colorado, we’ve proven that legal cannabis creates jobs; funds schools, not cartels; and boosts our economy, not our prison population, and I look forward to growing this industry. It’s an honor to have NORML’s endorsement, and I will proudly stand with them against Jeff Sessions or anyone else who tries to come after legal cannabis in Colorado.”

    To learn more about Jared’s campaign and find out how you can help him win in November CLICK HERE.

  • by Paul Armentano, NORML Deputy Director June 8, 2018

    President Donald Trump on Friday expressed verbal support for recently introduced, bi-partisan legislation that seeks to codify legal protections for state-sanctioned marijuana-related activities.

    In response to a question from reporters, the President acknowledged that he “probably will end up supporting” The Strengthening the Tenth Amendment Through Entrusting States (STATES) Act of 2018, sponsored by Senators Elizabeth Warren (D-MA) and Corey Gardner (R-CO). Majority Leader Mitch McConnell has also reportedly promised to permit a vote on the legislation.

    The bill mandates that the federal Controlled Substances Act “shall not apply to any person acting in compliance” the marijuana legalization laws of their state. It also amends federal law to explicitly remove industrial hemp from the definition of marijuana. A bipartisan House companion bill, sponsored by Reps. David Joyce (R-OH) and Earl Blumenauer (D-OR), is pending in the House of Representatives.

    Also today, Governors from 12 states: Alaska, California, Colorado, Maryland, Massachusetts, Nevada, New Jersey, New York, North Dakota, Oregon, Pennsylvania and Washington sent a letter to Congressional leadership urging passage of the STATES Act.

    In April, Sen. Gardner acknowledged that he had spoken with the President regarding the intent of his bill and that Trump “assured me that he will support a federalism-based legislative solution to fix this states’ rights issue once and for all.”

    Click here to send a message to your lawmakers in support of the States Act. 

  • by Paul Armentano, NORML Deputy Director April 13, 2018

    Republican Senator Cory Gardner (CO) says that he has received a verbal commitment from President Donald Trump specifying that the administration will not take action to disrupt marijuana markets in states that legally regulate the substance.

    “Since the campaign, President Trump has consistently supported states’ rights to decide for themselves how best to approach marijuana,” Gardner told the Associated Press. “Late Wednesday, I received a commitment from the President that the Department of Justice’s rescission of the Cole memo will not impact Colorado’s legal marijuana industry.”

    He added: “Furthermore, President Trump has assured me that he will support a federalism-based legislative solution to fix this states’ rights issue once and for all. Because of these commitments, I have informed the Administration that I will be lifting my remaining holds on Department of Justice nominees.”

    In January, US Attorney General Jeff Sessions rescinded Obama-era guidelines directing federal prosecutors not to take action against those who were compliant with state-sanctioned cannabis regulations. In response to that decision, Rep. Gardner had vowed to block all nominees for Justice Department jobs.

    On Friday, White House legislative affairs director Marc Short said, Trump “does respect Colorado’s right to decide for themselves how to best approach this issue.” At a separate press conference, White House Press Secretary Sarah Huckabee Sanders confirmed that the President and Sen. Gardner had spoken about the issue and that the senator’s account is “accurate.”

    In response to the administration’s pledge, NORML Director Erik Altieri stated: “We applaud this commitment from President Trump, who promised during his campaign to take a federalist approach with regard to marijuana policy. That campaign promise was not reflected by Trump’s appointment of longtime marijuana prohibitionist Jeff Sessions to the position of Attorney General or any of the actions that Sessions has taken since becoming the nation’s top law enforcement officer.”

    “With the President now reiterating this commitment, it is time for Congress to do its part and swiftly move forward bipartisan legislation that explicitly provides states with the authority and autonomy to set their own marijuana policies absent the fear of federal incursion. Doing so would not only follow through one of Trump’s campaign promises, but it would codify the will of the overwhelming majority of Americans.”

    Senator Gardner reiterated that he and his colleagues “are continuing to work diligently on a bipartisan legislative solution (to the state/federal conflict) that can pass Congress and head to the President’s desk.”

    Thirty states have enacted statutes regulating the use of marijuana for medical purposes. Nine states have passed laws regulating marijuana use by adults. By contrast, federal law defines the marijuana plant as a ‘Schedule I’ prohibited substance that lacks “currently accepted medical use in treatment in the United States.”

  • by Paul Armentano, NORML Deputy Director May 4, 2017

    thumbs_upSpending legislation approved by Congress and signed into law reauthorizes language protecting state-sanctioned medical marijuana and industrial hemp programs.

    Specifically, Section 537 of the Consolidated Appropriations Act of 2017, states that no federal funds may be appropriated to “prevent any [state] from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana..” That language, initially passed by Congress in 2014, is now known as the Rohrabacher-Blumenauer amendment.

    A similarly worded amendment protecting state-sponsored hemp programs was also reauthorized.

    Both amendments will remain in effect until September 30, 2017, at which time members of Congress will once again need to either reauthorize the language or let the provisions expire.

    Forty-six states now recognize the therapeutic use of either cannabis or cannabidiol derived products. Thirty states recognize hemp as an industrial crop.

    Eight States regulate the adult use, production, and sale of marijuana. Non-medical, retail marijuana businesses operating in these states are not protected by these amendments and still remain vulnerable to federal interference or prosecution. In February, White House Press Secretary Sean Spicer publicly said that the administration was considering engaging in “greater enforcement” of federal anti-marijuana laws in these jurisdictions.

Page 1 of 3123